Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Nuclear receptor coactivator 4 (NCoA-4) (Androgen receptor coactivator 70 kDa protein) (70 kDa AR-activator) (70 kDa androgen receptor coactivator) (Androgen receptor-associated protein of 70 kDa) (Ret-activating protein ELE1)

 NCOA4_HUMAN             Reviewed;         614 AA.
Q13772; A8K8W5; B4E260; E9PAV7; J3KQN8; Q14239;
01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
01-NOV-1996, sequence version 1.
12-SEP-2018, entry version 182.
RecName: Full=Nuclear receptor coactivator 4;
Short=NCoA-4;
AltName: Full=Androgen receptor coactivator 70 kDa protein;
Short=70 kDa AR-activator;
Short=70 kDa androgen receptor coactivator;
AltName: Full=Androgen receptor-associated protein of 70 kDa;
AltName: Full=Ret-activating protein ELE1;
Name=NCOA4; Synonyms=ARA70, ELE1, RFG;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Prostatic carcinoma;
PubMed=8643607; DOI=10.1073/pnas.93.11.5517;
Yeh S., Chang C.;
"Cloning and characterization of a specific coactivator, ARA70, for
the androgen receptor in human prostate cells.";
Proc. Natl. Acad. Sci. U.S.A. 93:5517-5521(1996).
[2]
NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL REARRANGEMENT WITH RET.
TISSUE=Thyroid;
PubMed=8290261;
Santoro M., Dathan N.A., Berlingieri M.T., Bongarzone I., Paulin C.,
Grieco M., Pierotti M.A., Vecchio G., Fusco A.;
"Molecular characterization of RET/PTC3; a novel rearranged version of
the RETproto-oncogene in a human thyroid papillary carcinoma.";
Oncogene 9:509-516(1994).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS ALPHA; 3 AND 4).
TISSUE=Testis, and Trachea;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Melanoma;
PubMed=17974005; DOI=10.1186/1471-2164-8-399;
Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
"The full-ORF clone resource of the German cDNA consortium.";
BMC Genomics 8:399-399(2007).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15164054; DOI=10.1038/nature02462;
Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
"The DNA sequence and comparative analysis of human chromosome 10.";
Nature 429:375-381(2004).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA).
TISSUE=Placenta;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[8]
NUCLEOTIDE SEQUENCE [MRNA] OF 1-238, AND CHROMOSOMAL REARRANGEMENT
WITH RET.
TISSUE=Thyroid tumor;
PubMed=8187085;
Bongarzone I., Butti M.G., Coronelli S., Borrello M.G., Santoro M.,
Mondellini P., Pilotti S., Fusco A., Della Porta G., Pierotti M.A.;
"Frequent activation of ret protooncogene by fusion with a new
activating gene in papillary thyroid carcinomas.";
Cancer Res. 54:2979-2985(1994).
[9]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA AND BETA), AND VARIANTS
LEU-94; LEU-154; ARG-350 AND PRO-561.
TISSUE=Cervix carcinoma, Mammary cancer, and Prostatic carcinoma;
PubMed=9892017; DOI=10.1210/mend.13.1.0214;
Alen P., Claessens F., Schoenmakers E., Swinnen J.V., Verhoeven G.,
Rombauts W., Peeters B.;
"Interaction of the putative androgen receptor-specific coactivator
ARA70/ELE1alpha with multiple steroid receptors and identification of
an internally deleted ELE1beta isoform.";
Mol. Endocrinol. 13:117-128(1999).
[10]
FUNCTION.
PubMed=10347167; DOI=10.1074/jbc.274.23.16147;
Heinlein C.A., Ting H.-J., Yeh S., Chang C.;
"Identification of ARA70 as a ligand-enhanced coactivator for the
peroxisome proliferator-activated receptor gamma.";
J. Biol. Chem. 274:16147-16152(1999).
-!- FUNCTION: Enhances the androgen receptor transcriptional activity
in prostate cancer cells. Ligand-independent coactivator of the
peroxisome proliferator-activated receptor (PPAR) gamma.
{ECO:0000269|PubMed:10347167}.
-!- SUBUNIT: Interacts with the androgen receptor and the retinoid X
receptor (RXR) in a ligand-dependent manner.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=4;
Comment=Additional isoforms seem to exist.;
Name=Alpha;
IsoId=Q13772-1; Sequence=Displayed;
Name=Beta;
IsoId=Q13772-2; Sequence=VSP_003409;
Note=No experimental confirmation available.;
Name=3;
IsoId=Q13772-3; Sequence=VSP_046348;
Note=No experimental confirmation available. Ref.3 (BAG65022)
sequence is in conflict in position: 8:F->V. {ECO:0000305};
Name=4;
IsoId=Q13772-4; Sequence=VSP_046348, VSP_046349;
Note=No experimental confirmation available. Ref.3 (AK310849)
sequence is in conflict in position: 8:F->V. {ECO:0000305};
-!- TISSUE SPECIFICITY: Widely expressed. Also detected in adipose
tissues and in different cell lines. Isoform Beta is only
expressed in testis.
-!- DISEASE: Note=A chromosomal aberration involving NCOA4 is found in
papillary thyroid carcinomas (PTCs). Inversion
inv(10)(q11.2;q11.2) generates the RET/NCOA4 (PTC3) oncogene.
{ECO:0000269|PubMed:8187085, ECO:0000269|PubMed:8290261}.
-!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
and Haematology;
URL="http://atlasgeneticsoncology.org/Genes/NCOA4ID218ch10q11.html";
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; L49399; AAC37591.1; -; mRNA.
EMBL; X77548; CAA54673.1; -; mRNA.
EMBL; AK292480; BAF85169.1; -; mRNA.
EMBL; AK304123; BAG65022.1; -; mRNA.
EMBL; AK310849; -; NOT_ANNOTATED_CDS; mRNA.
EMBL; AL162047; CAB82390.1; -; mRNA.
EMBL; AL450342; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CH471260; EAW53686.1; -; Genomic_DNA.
EMBL; BC001562; AAH01562.1; -; mRNA.
EMBL; X71413; CAA50536.1; -; mRNA.
CCDS; CCDS73092.1; -. [Q13772-1]
CCDS; CCDS73093.1; -. [Q13772-3]
CCDS; CCDS73094.1; -. [Q13772-4]
PIR; S61532; S61532.
RefSeq; NP_001138732.1; NM_001145260.1. [Q13772-4]
RefSeq; NP_001138733.1; NM_001145261.1. [Q13772-3]
RefSeq; NP_001138734.1; NM_001145262.1. [Q13772-1]
RefSeq; NP_001138735.1; NM_001145263.1. [Q13772-1]
RefSeq; NP_005428.1; NM_005437.3. [Q13772-1]
UniGene; Hs.643658; -.
UniGene; Hs.709644; -.
PDB; 1T5Z; X-ray; 2.30 A; B=322-336.
PDBsum; 1T5Z; -.
ProteinModelPortal; Q13772; -.
SMR; Q13772; -.
BioGrid; 113726; 35.
DIP; DIP-5957N; -.
IntAct; Q13772; 14.
STRING; 9606.ENSP00000395465; -.
iPTMnet; Q13772; -.
PhosphoSitePlus; Q13772; -.
BioMuta; NCOA4; -.
DMDM; 8928226; -.
EPD; Q13772; -.
MaxQB; Q13772; -.
PaxDb; Q13772; -.
PeptideAtlas; Q13772; -.
PRIDE; Q13772; -.
ProteomicsDB; 59681; -.
ProteomicsDB; 59682; -. [Q13772-2]
DNASU; 8031; -.
Ensembl; ENST00000578454; ENSP00000463027; ENSG00000266412. [Q13772-4]
Ensembl; ENST00000579039; ENSP00000463455; ENSG00000266412. [Q13772-3]
Ensembl; ENST00000581486; ENSP00000462943; ENSG00000266412. [Q13772-1]
Ensembl; ENST00000583565; ENSP00000463476; ENSG00000266412. [Q13772-1]
Ensembl; ENST00000585132; ENSP00000464054; ENSG00000266412. [Q13772-1]
GeneID; 8031; -.
KEGG; hsa:8031; -.
UCSC; uc001jis.5; human. [Q13772-1]
CTD; 8031; -.
DisGeNET; 8031; -.
EuPathDB; HostDB:ENSG00000266412.5; -.
GeneCards; NCOA4; -.
HGNC; HGNC:7671; NCOA4.
HPA; HPA051260; -.
HPA; HPA065208; -.
MalaCards; NCOA4; -.
MIM; 601984; gene.
neXtProt; NX_Q13772; -.
OpenTargets; ENSG00000266412; -.
Orphanet; 146; Papillary or follicular thyroid carcinoma.
PharmGKB; PA31473; -.
eggNOG; ENOG410IHT6; Eukaryota.
eggNOG; ENOG410YJ5B; LUCA.
GeneTree; ENSGT00390000008403; -.
HOGENOM; HOG000013175; -.
HOVERGEN; HBG052584; -.
InParanoid; Q13772; -.
KO; K09289; -.
OMA; PLQEEHN; -.
OrthoDB; EOG091G049Z; -.
PhylomeDB; Q13772; -.
TreeFam; TF333204; -.
SIGNOR; Q13772; -.
ChiTaRS; NCOA4; human.
EvolutionaryTrace; Q13772; -.
GeneWiki; NCOA4; -.
GenomeRNAi; 8031; -.
PRO; PR:Q13772; -.
Proteomes; UP000005640; Chromosome 10.
Bgee; ENSG00000266412; Expressed in 239 organ(s), highest expression level in trabecular bone tissue.
CleanEx; HS_NCOA4; -.
ExpressionAtlas; Q13772; baseline and differential.
Genevisible; Q13772; HS.
GO; GO:0044754; C:autolysosome; IDA:MGI.
GO; GO:0005634; C:nucleus; TAS:ProtInc.
GO; GO:0050681; F:androgen receptor binding; NAS:UniProtKB.
GO; GO:0003713; F:transcription coactivator activity; TAS:ProtInc.
GO; GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB.
GO; GO:0006879; P:cellular iron ion homeostasis; IEA:Ensembl.
GO; GO:0008584; P:male gonad development; TAS:ProtInc.
GO; GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB.
GO; GO:0006622; P:protein targeting to lysosome; IDA:MGI.
GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
InterPro; IPR022174; ARA70.
Pfam; PF12489; ARA70; 2.
1: Evidence at protein level;
3D-structure; Activator; Alternative splicing;
Chromosomal rearrangement; Complete proteome; Polymorphism;
Proto-oncogene; Reference proteome; Transcription;
Transcription regulation.
CHAIN 1 614 Nuclear receptor coactivator 4.
/FTId=PRO_0000094410.
SITE 238 239 Breakpoint for rearrangement to form
RET/PTC3 oncogene.
VAR_SEQ 1 1 M -> MGAQLTTFALAGAVRRM (in isoform 3 and
isoform 4).
{ECO:0000303|PubMed:14702039}.
/FTId=VSP_046348.
VAR_SEQ 239 565 Missing (in isoform Beta).
{ECO:0000303|PubMed:9892017}.
/FTId=VSP_003409.
VAR_SEQ 614 614 M -> AYFKMNFQDVTVGNFQIPCGF (in isoform
4). {ECO:0000303|PubMed:14702039}.
/FTId=VSP_046349.
VARIANT 94 94 S -> L. {ECO:0000269|PubMed:9892017}.
/FTId=VAR_009190.
VARIANT 154 154 F -> L. {ECO:0000269|PubMed:9892017}.
/FTId=VAR_009191.
VARIANT 350 350 C -> R. {ECO:0000269|PubMed:9892017}.
/FTId=VAR_009192.
VARIANT 474 474 P -> R (in dbSNP:rs1132111).
/FTId=VAR_014928.
VARIANT 561 561 L -> P. {ECO:0000269|PubMed:9892017}.
/FTId=VAR_009193.
MUTAGEN 95 96 LL->AA: Decreased interaction with PPAR
and RXR.
CONFLICT 71 71 Y -> H (in Ref. 3; BAG65022).
{ECO:0000305}.
CONFLICT 162 162 I -> T (in Ref. 8; CAA50536).
{ECO:0000305}.
CONFLICT 183 183 G -> S (in Ref. 8; CAA50536).
{ECO:0000305}.
CONFLICT 271 271 K -> R (in Ref. 3; AK310849).
{ECO:0000305}.
HELIX 327 333 {ECO:0000244|PDB:1T5Z}.
SEQUENCE 614 AA; 69726 MW; 36B6D97C7D072BFF CRC64;
MNTFQDQSGS SSNREPLLRC SDARRDLELA IGGVLRAEQQ IKDNLREVKA QIHSCISRHL
ECLRSREVWL YEQVDLIYQL KEETLQQQAQ QLYSLLGQFN CLTHQLECTQ NKDLANQVSV
CLERLGSLTL KPEDSTVLLF EADTITLRQT ITTFGSLKTI QIPEHLMAHA SSANIGPFLE
KRGCISMPEQ KSASGIVAVP FSEWLLGSKP ASGYQAPYIP STDPQDWLTQ KQTLENSQTS
SRACNFFNNV GGNLKGLENW LLKSEKSSYQ KCNSHSTTSS FSIEMEKVGD QELPDQDEMD
LSDWLVTPQE SHKLRKPENG SRETSEKFKL LFQSYNVNDW LVKTDSCTNC QGNQPKGVEI
ENLGNLKCLN DHLEAKKPLS TPSMVTEDWL VQNHQDPCKV EEVCRANEPC TSFAECVCDE
NCEKEALYKW LLKKEGKDKN GMPVEPKPEP EKHKDSLNMW LCPRKEVIEQ TKAPKAMTPS
RIADSFQVIK NSPLSEWLIR PPYKEGSPKE VPGTEDRAGK QKFKSPMNTS WCSFNTADWV
LPGKKMGNLS QLSSGEDKWL LRKKAQEVLL NSPLQEEHNF PPDHYGLPAV CDLFACMQLK
VDKEKWLYRT PLQM


Related products :

Catalog number Product name Quantity
EIAAB26566 70 kDa androgen receptor coactivator,70 kDa AR-activator,Androgen receptor coactivator 70 kDa protein,Androgen receptor-associated protein of 70 kDa,ARA70,ELE1,Homo sapiens,Human,NCOA4,NCoA-4,Nuclear
EIAAB26557 mNRC-1,Mouse,Mus musculus,Ncoa1,NCoA-1,Nuclear receptor coactivator 1,Nuclear receptor coactivator protein 1,Src1,SRC-1,Steroid receptor coactivator 1
EIAAB42153 Androgen receptor coactivator 55 kDa protein,Androgen receptor-associated protein of 55 kDa,ARA55,Hic-5,Homo sapiens,Human,Hydrogen peroxide-inducible clone 5 protein,TGFB1I1,Transforming growth facto
EIAAB43044 Androgen receptor coactivator 160 kDa protein,Androgen receptor-associated protein of 160 kDa,Ara160,Gm153,Mouse,Mus musculus,TATA element modulatory factor,TMF,Tmf1
EIAAB43043 Androgen receptor coactivator 160 kDa protein,Androgen receptor-associated protein of 160 kDa,ARA160,Homo sapiens,Human,TATA element modulatory factor,TMF,TMF1
OBT1799 SRC3 (Steroid receptor coactivator 3), Nuclear receptor coactivator 3 encoded by exon 13 (NCOA3), Thyroid Hormone Receptor Activator Molecule 1 (TRAM1), Receptor_Associated Coactivator 3 (RAC3) , Ampl 0.1 mg.
OBT1799 SRC3 (Steroid receptor coactivator 3), Nuclear receptor coactivator 3 encoded by exon 13 (NCOA3), Thyroid Hormone Receptor Activator Molecule 1 (TRAM1), Receptor_Associated Coactivator 3 (RAC3) , Ampl 0.1 mg.
27-539 SKIIP (Nuclear Protein SkiP, nuclear receptor coactivator NCoA-62, ski-interacting protein) is a member of the SNW gene family, encodes a coactivator that enhances transcription from some Pol II promo 0.05 mg
EIAAB26559 NCOA1,NCoA-1,Nuclear receptor coactivator 1,Pig,SRC1,SRC-1,Steroid receptor coactivator 1,Sus scrofa
EIAAB27930 Androgen receptor coactivator 267 kDa protein,Androgen receptor-associated protein of 267 kDa,ARA267,H3-K36-HMTase,H4-K20-HMTase,Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 speci
EIAAB26574 140 kDa estrogen receptor-associated protein,ERAP140,ESNA1,Estrogen nuclear receptor coactivator 1,Homo sapiens,Human,Nbla00052,Nbla10993,NCOA7,Nuclear receptor coactivator 7
EIAAB26570 Activating signal cointegrator 2,Aib3,Amplified in breast cancer protein 3,ASC-2,Cancer-amplified transcriptional coactivator ASC-2,Ncoa6,NRC,Nuclear receptor coactivator 6,Nuclear receptor coactivato
EIAAB26567 CIA,Coactivator independent of AF-2,Mouse,Mus musculus,Ncoa5,NCoA-5,Nuclear receptor coactivator 5
EIAAB26568 CIA,Coactivator independent of AF-2,Homo sapiens,Human,KIAA1637,NCOA5,NCoA-5,Nuclear receptor coactivator 5
28-872 RNF14 contains a RING zinc finger, a motif known to be involved in protein-protein interactions. This protein interacts with androgen receptor (AR) and may function as a coactivator that induces AR ta 0.1 mg
OBT1796 SRC2 (Steroid receptor coactivator 2), Nuclear receptor coactivator 2 encoded by exon 26, Transcriptional Intermediary Factor 2 (TIF2), Glucocorticoid Receptor_Interacting Protein (GRIP1), Rabbit anti 0.1 mg.
OBT1796 SRC2 (Steroid receptor coactivator 2), Nuclear receptor coactivator 2 encoded by exon 26, Transcriptional Intermediary Factor 2 (TIF2), Glucocorticoid Receptor_Interacting Protein (GRIP1), Rabbit anti 0.1 mg.
EIAAB26562 Glucocorticoid receptor-interacting protein 1,Grip1,GRIP-1,Mouse,Mus musculus,Ncoa2,NCoA-2,Nuclear receptor coactivator 2,Tif2,Transcriptional intermediary factor 2
EIAAB26571 Activating signal cointegrator 2,Aib3,Amplified in breast cancer protein 3,ASC-2,Cancer-amplified transcriptional coactivator ASC-2,Mouse,Mus musculus,Ncoa6,NRC,Nuclear receptor coactivator 6,Nuclear
EIAAB26565 ACTR,Aib1,AIB-1,Amplified in breast cancer-1 protein homolog,CBP-interacting protein,Mouse,Mus musculus,Ncoa3,NCoA-3,Nuclear receptor coactivator 3,p_CIP,pCIP,Pcip,Rac3,RAC-3,Receptor-associated coact
OBT1797 SRC1 (Steroid receptor coactivator 1), Nuclear receptor coactivator 1 encoded by exon 12 (NCOA1), Rabbit anti_Human, Mouse; IP 0.1 mg.
OBT1798 SRC1 (Steroid receptor coactivator 1), Nuclear receptor coactivator 1 encoded by exon 23 (NCOA1), Rabbit anti_Human, Mouse; IP 0.1 mg.
20-272-192203 AIB1 - Mouse monoclonal [AC3] to AIB1; EC 2.3.1.48; NCoA-3; Thyroid hormone receptor activator molecule 1; TRAM-1; ACTR; Receptor-associated coactivator 3; RAC-3; Amplified in breast cancer-1 protein; 0.05 mg
18-272-195032 SRC3 - Rabbit polyclonal to SRC3; EC 2.3.1.48; NCoA-3; Thyroid hormone receptor activator molecule 1; TRAM-1; ACTR; Receptor-associated coactivator 3; RAC-3; Amplified in breast cancer-1 protein; AIB- 0.05 mg
18-272-195029 SRC3 - Rabbit polyclonal to SRC3; EC 2.3.1.48; NCoA-3; Thyroid hormone receptor activator molecule 1; TRAM-1; ACTR; Receptor-associated coactivator 3; RAC-3; Amplified in breast cancer-1 protein; AIB- 0.05 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur